Molecular imaging and radioimmunoguided surgery

Seminars in Pediatric Surgery

Volumn 15, Issue 4, 2006, Pages 259-266

  Mery, Carlos M ^a,b   Shafi, Bilal M ^a,c   Binyamin, Gary ^a  

^a STANFORD UNIVERSITY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Colorectal cancer; Immunoscintigraphy; Molecular imaging; Monoclonal antibodies; Nuclear medicine; Radioimmunodetection; Radioimmunoguided surgery; Radioisotopes

Indexed keywords

ANTIBODY; ANTIGEN; CETUXIMAB; EDRECOLOMAB; INDIUM 111; IODINE 123; IODINE 125; IODINE 131; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 170H.82; MONOCLONAL ANTIBODY A10; MONOCLONAL ANTIBODY A7; MONOCLONAL ANTIBODY B.72.3; MONOCLONAL ANTIBODY BRE 3; MONOCLONAL ANTIBODY CC49; MONOCLONAL ANTIBODY FO23C5; MONOCLONAL ANTIBODY H17E2; MONOCLONAL ANTIBODY HMFG1; MONOCLONAL ANTIBODY HU2PLAP; MONOCLONAL ANTIBODY IMMU 4; MONOCLONAL ANTIBODY J28; MONOCLONAL ANTIBODY L6; MONOCLONAL ANTIBODY OC 125; MONOCLONAL ANTIBODY SM3; MONOCLONAL ANTIBODY T84.66; RADIOISOTOPE; TECHNETIUM 99M; THALLIUM 201; TRASTUZUMAB; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ARTICLE; CANCER DIAGNOSIS; CANCER SURVIVAL; COLORECTAL CANCER; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FALSE POSITIVE RESULT; HUMAN; IMMUNOSCINTIGRAPHY; INTRAOPERATIVE PERIOD; MEASUREMENT; MOLECULAR IMAGING; OCCULT CANCER; PEROPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RADIOACTIVITY; RADIOIMMUNOASSAY; RADIOIMMUNOGUIDED SURGERY; SCINTILLATION CAMERA; SCINTISCANNING; STATISTICAL SIGNIFICANCE; SURGEON; TREATMENT OUTCOME;

CHILD; COLORECTAL NEOPLASMS; EQUIPMENT DESIGN; GAMMA CAMERAS; HUMANS; NEOPLASMS; NEOPLASMS, UNKNOWN PRIMARY; OUTCOME ASSESSMENT (HEALTH CARE); POSITRON-EMISSION TOMOGRAPHY; RADIOIMMUNODETECTION; SENSITIVITY AND SPECIFICITY; SURGERY, COMPUTER-ASSISTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 33750006745     PISSN: 10558586     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.sempedsurg.2006.07.005     Document Type: Article

References (62)

1. Kohler G., and Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256 (1975) 495-497
2. Parslow T.G. Immunoglobulins and immunoglobulin genes. In: Parslow T.G., Stites D.P., Terr A.I., et al. (Eds). Medical Immunology (2001), McGraw Hill, New York, NY
3. Nieroda C.A., Milenic D.E., Colcher D., et al. Monoclonal antibodies for use in radioimmunoguided surgery (RIGS). In: Martin E.W. (Ed). Radioimmunoguided Surgery (RIGS) in the Detection and Treatment of Colorectal Cancer (1994), R.G. Landes Company, Austin, TX
4. Goel A., and Batra S.K. Antibody constructs for radioimmunodiagnosis and treatment of human pancreatic cancer. Teratog Carcinog Mutagen 21 (2001) 45-57
5. Van de Wiele C., Revets H., and Mertens N. Radioimmunoimaging. Advances and prospects. Q J Nucl Med Mol Imaging 48 (2004) 317-325
6. Sergides I.G., Austin R.C., and Winslet M.C. Radioimmunodetection: technical problems and methods of improvement. Eur J Surg Oncol 25 (1999) 529-539
7. Xiao J., Horst S., Hinkle G., et al. Pharmacokinetics and clinical evaluation of 125I-radiolabeled humanized CC49 monoclonal antibody (HuCC49deltaC(H)2) in recurrent and metastatic colorectal cancer patients. Cancer Biother Radiopharm 20 (2005) 16-26
8. Borjesson P.K., Postema E.J., de Bree R., et al. Radioimmunodetection and radioimmunotherapy of head and neck cancer. Oral Oncol 40 (2004) 761-772
9. Thor A., Ohuchi N., Szpak C.A., et al. Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3. Cancer Res 46 (1986) 3118-3124
10. Divgi C.R., Scott A.M., McDermott K., et al. Clinical comparison of radiolocalization of two monoclonal antibodies (mAbs) against the TAG-72 antigen. Nucl Med Biol 21 (1994) 9-15
11. Moffat Jr. F.L., Pinsky C.M., Hammershaimb L., et al., The Immunomedics Study Group. Clinical utility of external immunoscintigraphy with the IMMU-4 technetium-99m Fab' antibody fragment in patients undergoing surgery for carcinoma of the colon and rectum: results of a pivotal, phase III trial. J Clin Oncol 14 (1996) 2295-2305
12. Roselli M., Buonomo O., Piazza A., et al. Novel clinical approaches in monoclonal antibody-based management in colorectal cancer patients: radioimmunoguided surgery and antigen augmentation. Semin Surg Oncol 15 (1998) 254-262
13. Thurston M.O. Development of the gamma-detecting probe for radioimmunoguided surgery. In: Martin E.W. (Ed). Radioimmunoguided Surgery (RIGS) in the Detection and Treatment of Colorectal Cancer (1994), R.G. Landes Company, Austin, TX
14. Maurer A.H., Urbain J.-L.C., Malmud L.S., et al. Radionuclide imaging: general principles. A Textbook of Medical Imaging. In: Grainger R.G., Allison D.J., Adam A., et al. (Eds). Grainger & Allison's Diagnostic Radiology (2001), Churchill Livingstone, London
15. Schuster D.M., and Halkar R.K. Molecular imaging in breast cancer. Radiol Clin North Am 42 (2004) 885-908 vi-vii
16. Hinkle G.H., and Laven D.L. Radionuclides. In: Martin E.W. (Ed). Radioimmunoguided Surgery (RIGS) in the Detection and Treatment of Colorectal Cancer (1994), R.G. Landes Company, Austin, TX
17. Goldenberg D.M., Sharkey R.M., Paganelli G., et al. Antibody pretargeting advances cancer radioimmunodetection and radioimmunotherapy. J Clin Oncol 24 (2006) 823-834
18. Hoffman E.J., Tornai M.P., Janecek M., et al. Intraoperative probes and imaging probes. Eur J Nucl Med 26 (1999) 913-935
19. Schneebaum S., Even-Sapir E., Cohen M., et al. Clinical applications of gamma-detection probes: radioguided surgery. Eur J Nucl Med 26 (1999) S26-S35
20. Martin E.W., Barnes J.A., and Thurston M.O. Introduction: the RIGS concept. In: Martin E.W. (Ed). Radioimmunoguided Surgery (RIGS) in the Detection and Treatment of Colorectal Cancer (1994), R.G. Landes Company, Austin, TX
21. Aitken D.R., Hinkle G.H., Thurston M.O., et al. A gamma-detecting probe for radioimmune detection of CEA-producing tumors. Successful experimental use and clinical case report. Dis Colon Rectum 27 (1984) 279-282
22. Martin D.T., Hinkle G.H., Tuttle S., et al. Intraoperative radioimmunodetection of colorectal tumor with a hand-held radiation detector. Am J Surg 150 (1985) 672-675
23. Martinez D.A., Barbera-Guillem E., LaValle G.J., et al. Radioimmunoguided surgery for gastrointestinal malignancies: an analysis of 14 years of clinical experience. Cancer Control 4 (1997) 505-516
24. Arnold M.W., Schneebaum S., and Martin Jr. E.W. Radioimmunoguided surgery in the treatment and evaluation of rectal cancer patients. Cancer Control 3 (1996) 42-45
25. Nag S., Martinez-Monge R., Nieroda C., et al. Radioimmunoguided-intraoperative radiation therapy in colorectal carcinoma: a new technique to precisely define the clinical target volume. Int J Radiat Oncol Biol Phys 44 (1999) 133-137
26. Arnold M.W., Young D.M., Hitchcock C.L., et al. Staging of colorectal cancer: biology vs. morphology. Dis Colon Rectum 41 (1998) 1482-1487
27. Cohen A.M., Martin Jr. E.W., Lavery I., et al. Radioimmunoguided surgery using iodine 125 B72.3 in patients with colorectal cancer. Arch Surg 126 (1991) 349-352
28. Arnold M.W., Schneebaum S., Berens A., et al. Radioimmunoguided surgery challenges traditional decision making in patients with primary colorectal cancer. Surgery 112 (1992) 624-629 discussion 629-30
29. Filez L., Penninckx F., Ectors N., et al. Radioimmunoguided surgery for colorectal carcinoma. Hepatogastroenterology 46 (1999) 691-700
30. Schneebaum S., Troitsa A., Haddad R., et al. Immunoguided lymph node dissection in colorectal cancer: a new challenge?. World J Surg 25 (2001) 1495-1498 discussion 1499
31. Cote R.J., Houchens D.P., Hitchcock C.L., et al. Intraoperative detection of occult colon cancer micrometastases using 125 I-radiolabled monoclonal antibody CC49. Cancer 77 (1996) 613-620
32. Schneebaum S., Arnold M.W., Houchens D.P., et al. The significance of intraoperative periportal lymph node metastasis identification in patients with colorectal carcinoma. Cancer 75 (1995) 2809-2817
33. Martin Jr. E.W., and Carey L.C. Second-look surgery for colorectal cancer. The second time around. Ann Surg 214 (1991) 321-325 discussion 326-7
34. Bertsch D.J., Burak Jr. W.E., Young D.C., et al. Radioimmunoguided surgery for colorectal cancer. Ann Surg Oncol 3 (1996) 310-316
35. Bertsch D.J., Burak Jr. W.E., Young D.C., et al. Radioimmunoguided Surgery system improves survival for patients with recurrent colorectal cancer. Surgery 118 (1995) 634-638 discussion 638-9
36. Kalofonos H.P., Karamouzis M.V., and Epenetos A.A. Radioimmunoscintigraphy in patients with ovarian cancer. Acta Oncol 40 (2001) 549-557
37. DeNardo S.J. Radioimmunodetection and therapy of breast cancer. Semin Nucl Med 35 (2005) 143-151
38. Percivale P., Bertoglio S., Meszaros P., et al. Radioimmunoguided surgery after primary treatment of locally advanced breast cancer. J Clin Oncol 14 (1996) 1599-1603
39. Kim J.C., Hong H.K., Roh S.A., et al. Efficient targeting of gastric cancer cells using radiolabeled anti-carcinoembryonic antigen-specific T84.66 fragments in experimental radioimmunoguided surgery. Anticancer Res 24 (2004) 663-670
40. Ellis R.J., Kim E.Y., Conant R., et al. Radioimmunoguided imaging of prostate cancer foci with histopathological correlation. Int J Radiat Oncol Biol Phys 49 (2001) 1281-1286
41. Agnese D.M., Abdessalam S.F., Burak Jr. W.E., et al. Pilot study using a humanized CC49 monoclonal antibody (HuCC49DeltaCH2) to localize recurrent colorectal carcinoma. Ann Surg Oncol 11 (2004) 197-202
42. Arnold M.W., Schneebaum S., Berens A., et al. Intraoperative detection of colorectal cancer with radioimmunoguided surgery and CC49, a second-generation monoclonal antibody. Ann Surg 216 (1992) 627-632
43. Avital S., Haddad R., Troitsa A., et al. Radioimmunoguided surgery for recurrent colorectal cancer manifested by isolated CEA elevation. Cancer 89 (2000) 1692-1698
44. Bertoglio S., Benevento A., Percivale P., et al. Radioimmunoguided surgery benefits in carcinoembryonic antigen-directed second-look surgery in the asymptomatic patient after curative resection of colorectal cancer. Semin Surg Oncol 15 (1998) 263-267
45. Burak Jr. W.E., Schneebaum S., Kim J.A., et al. Pilot study evaluating the intraoperative localization of radiolabeled monoclonal antibody CC83 in patients with metastatic colorectal carcinoma. Surgery 118 (1995) 103-108
46. Gu J., Zhao J., Li Z., et al. Clinical application of radioimmunoguided surgery in colorectal cancer using 125I-labeled carcinoembryonic antigen-specific monoclonal antibody submucosally. Dis Colon Rectum 46 (2003) 1659-1666
47. Haddad R., Avital S., Troitsa A., et al. Benefits of radioimmunoguided surgery for pelvic recurrence. Eur J Surg Oncol 27 (2001) 298-301
48. Hladik P., Vizda J., Bedrna J., et al. Immunoscintigraphy and intra-operative radioimmunodetection in the treatment of colorectal carcinoma. Colorectal Dis 3 (2001) 380-386
49. Lechner P., Lind P., Snyder M., et al. Probe-guided surgery for colorectal cancer. Recent Results Cancer Res 157 (2000) 273-280
50. Percivale P., Bertoglio S., Meszaros P., et al. Radioimmunoguided surgery with different iodine-125 radiolabeled monoclonal antibodies in recurrent colorectal cancer. Semin Surg Oncol 15 (1998) 231-234
51. Renda A., Iovino F., Capasso L., et al. Radioimmunoguided surgery in colorectal cancer: a 6-year experience with four different technical solutions. Semin Surg Oncol 15 (1998) 226-230
52. Sickle-Santanello B.J., O'Dwyer P.J., Mojzisik C., et al. Radioimmunoguided surgery using the monoclonal antibody B72.3 in colorectal tumors. Dis Colon Rectum 30 (1987) 761-764
53. Badellino F., Bertoglio S., Mariani G., et al. Use of radioimmunoguided surgery after induction chemotherapy in locally advanced breast cancer. Semin Surg Oncol 15 (1998) 245-248
54. Burak Jr. W.E., DePalatis L., Mosic J.L., et al. Radioimmunoguided breast surgery using radiolabeled antibody NR-LU-10 FAB: a pilot study. Tumori 87 (2001) 142-146
55. Nieroda C.A., Mojzisik C., Sardi A., et al. Staging of carcinoma of the breast using a hand-held gamma detecting probe and monoclonal antibody B72.3. Surg Gynecol Obstet 169 (1989) 35-40
56. Bell J., Mojzisik C., Hinkle Jr. G., et al. Intraoperative radioimmunodetection of ovarian cancer using monoclonal antibody B72.3 and a portable gamma-detecting probe. Obstet Gynecol 76 (1990) 607-611
57. Ind T.E., Granowska M., Britton K.E., et al. Peroperative radioimmunodetection of ovarian carcinoma using a hand-held gamma detection probe. Br J Cancer 70 (1994) 1263-1266
58. Lucisano E., and Bertoglio S. Role of radioimmunoguided surgery using iodine-125-labeled B72.3 monoclonal antibody in gastric cancer surgery. Semin Surg Oncol 15 (1998) 212-214
59. Mussa A., Sandrucci S., Mobiglia A., et al. Role of radioimmunolocalization in the staging of gastric carcinoma. Semin Surg Oncol 15 (1998) 209-211
60. LaValle G.J., Martinez D.A., Sobel D., et al. Assessment of disseminated pancreatic cancer: a comparison of traditional exploratory laparotomy and radioimmunoguided surgery. Surgery 122 (1997) 867-871 discussion 871-3
61. Grazia M., Bini A., Stella F., et al. Radioimmunoguided surgery and intraoperative lung cancer staging. Semin Surg Oncol 15 (1998) 215-219
62. Badalament R.A., Burgers J.K., Petty L.R., et al. Radioimmunoguided radical prostatectomy and lymphadenectomy. Cancer 71 (1993) 2268-2275